Rice Hall James & Associates LLC Buys New Shares in Avanos Medical, Inc. (NYSE:AVNS)

Rice Hall James & Associates LLC bought a new stake in Avanos Medical, Inc. (NYSE:AVNS) during the 4th quarter, HoldingsChannel reports. The firm bought 62,129 shares of the company’s stock, valued at approximately $989,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. KBC Group NV lifted its holdings in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares during the period. New York State Teachers Retirement System increased its stake in Avanos Medical by 2.0% in the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock valued at $1,737,000 after purchasing an additional 1,388 shares in the last quarter. Quarry LP bought a new stake in Avanos Medical in the third quarter valued at $42,000. Foundry Partners LLC increased its stake in Avanos Medical by 1.1% in the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,800 shares in the last quarter. Finally, Natixis Advisors LLC increased its stake in Avanos Medical by 13.6% in the third quarter. Natixis Advisors LLC now owns 21,452 shares of the company’s stock valued at $515,000 after purchasing an additional 2,574 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Trading Down 6.2 %

AVNS opened at $15.55 on Wednesday. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The company has a fifty day moving average price of $16.45 and a two-hundred day moving average price of $20.05. The company has a market cap of $714.63 million, a P/E ratio of 45.73 and a beta of 0.98. Avanos Medical, Inc. has a 1-year low of $14.98 and a 1-year high of $25.36.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.